Immunocore Holdings plc (FRA:6YG)
27.40
-1.00 (-3.52%)
Last updated: Oct 23, 2026, 9:55 PM CEST
Immunocore Holdings Employees
Immunocore Holdings had 524 employees as of December 31, 2025. The number of employees increased by 31 or 6.29% compared to the previous year.
Employees
524
Change (1Y)
31
Growth (1Y)
6.29%
Revenue / Employee
€719,575
Profits / Employee
€30,191
Market Cap
1.42B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 524 | 31 | 6.29% |
| Dec 31, 2024 | 493 | -4 | -0.80% |
| Dec 31, 2023 | 497 | 89 | 21.81% |
| Dec 31, 2022 | 408 | 84 | 25.93% |
| Dec 31, 2021 | 324 | 33 | 11.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 178,486 |
| Bayer Aktiengesellschaft | 87,830 |
| Siemens Healthineers AG | 74,300 |
| Merck KGaA | 62,136 |
| RHÖN-KLINIKUM Aktiengesellschaft | 19,120 |
| Drägerwerk AG & Co. KGaA | 16,009 |
| Gerresheimer AG | 13,301 |
| Carl Zeiss Meditec AG | 5,784 |
Immunocore Holdings News
- 10 days ago - Immunocore doses first patient in IMC-S118AI trial - TheFly
- 10 days ago - Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes - GlobeNewsWire
- 5 weeks ago - Immunocore Holdings Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 5 weeks ago - Immunocore achieves target patient enrollment in TEBE-AM clinical trial - TheFly
- 5 weeks ago - Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma - GlobeNewsWire
- 6 weeks ago - Immunocore Holdings Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 7 weeks ago - Immunocore to present at upcoming investor conferences - GlobeNewsWire
- 2 months ago - Immunocore reinstated with an Overweight at JPMorgan - TheFly